Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Adenosine A3 Receptor Agonists

Drugs that selectively bind to and activate ADENOSINE A3 RECEPTORS.
National Institutes of Health

Related topics

Related topics

4 relations
In Bloodaspects of radiation effectschemical synthesisstandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A binding kinetics study of human adenosine A3 receptor agonists
&NA; The human adenosine A3 (hA3) receptor has been suggested as a viable drug target in inflammatory diseases and in cancer. So… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Review
2018
Review
2018
Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature.
BACKGROUND Adenosine is a purine, with an adenine group and a ribose sugar, formed endogenously by ATP catabolism both… Expand
2016
2016
Pharmacology of the Adenosine A3 Receptor in the Vasculature and Essential Hypertension
Background Essential hypertension is considered to be a multifactorial disorder and its aetiology has yet to be clearly… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2006
2006
Dry eye disease treatment for adenosine a3 receptor agonists
 
2005
2005
Dry eye disease therapeutic adenosine a3 receptor agonists including Sjogren's Syndrome
 
1997
1997
Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo.
Adenosine and related analogs have been shown to regulate a variety of cell functions through different classes of adenosine… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE